We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

130 hedge funds and large institutions have $44M invested in Asensus Surgical, Inc. in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 36

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 141130 (-11)

43% less call options, than puts

Call options by funds: $552K | Put options by funds: $967K

48% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 23

52% less capital invested

Capital invested by funds: $92.3M → $44M (-$48.4M)

Holders
130
Holders Change
-11
Holders Change %
-7.8%
% of All Funds
2.85%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
41
Reduced
36
Closed
23
Calls
$552K
Puts
$967K
Net Calls
-$415K
Net Calls Change
+$674K
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
51
Maryland Capital Management
Maryland
$47K -$5.1K -375 -6%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$47K
JP Morgan Chase
53
JP Morgan Chase
New York
$44K -$1.86M -136,535 -96%
RJFSA
54
Raymond James Financial Services Advisors
Florida
$42K +$4.19K +308 +6%
Simplex Trading
55
Simplex Trading
Illinois
$40K +$381 +28 +0.6%
Stifel Financial
56
Stifel Financial
Missouri
$37K -$35K -2,573 -36%
Citigroup
57
Citigroup
New York
$37K -$12.8K -941 -17%
Invesco
58
Invesco
Georgia
$34K -$2.41K -177 -4%
Deutsche Bank
59
Deutsche Bank
Germany
$30K -$107K -7,888 -67%
Creative Planning
60
Creative Planning
Kansas
$27K -$1.59K -117 -3%
SPIA
61
Steward Partners Investment Advisory
New York
$27K +$3.24K +238 +7%
PP
62
Paloma Partners
Connecticut
$27K +$24.6K +1,812 +120%
Commonwealth Equity Services
63
Commonwealth Equity Services
Massachusetts
$25K +$3.48K +256 +9%
PAG
64
Private Advisor Group
New Jersey
$24K
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$24K
Legal & General Group
66
Legal & General Group
United Kingdom
$23K
Cambridge Investment Research Advisors
67
Cambridge Investment Research Advisors
Iowa
$22K -$136 -10 -0.4%
CAM
68
Cozad Asset Management
Illinois
$21K -$1.13K -83 -3%
AAS
69
Annex Advisory Services
Wisconsin
$21K
Ameriprise
70
Ameriprise
Minnesota
$21K +$22.2K +1,630 +164%
Victory Capital Management
71
Victory Capital Management
Texas
$21K +$34.8K +2,559 New
PNC Financial Services Group
72
PNC Financial Services Group
Pennsylvania
$20K +$25.6K +1,885 +350%
CAM
73
Crestone Asset Management
Colorado
$20K +$34.3K +2,520 New
AB
74
Amalgamated Bank
New York
$19K -$299 -22 -0.9%
BF
75
BOK Financial
Oklahoma
$19K

ASXC Hedge Fund Activity: Q3 2019 in Review

130 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2019, worth a combined $44M — down 52% from $92.3M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ASXC and 12 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 41 added.

The largest buyer was Luminus Management, opening a new position worth an estimated $2.38M. The largest seller was JP Morgan Chase, cutting an estimated $1.86M.

  • 130 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q3 2019, down from 141 in Q2 2019.
  • Funds reported $44M of Asensus Surgical, Inc. stock for Q3 2019, down 52% quarter-over-quarter.
  • 12 funds opened new Asensus Surgical, Inc. positions in Q3 2019 and 23 closed out, a net change of -11 holders.
  • The largest Asensus Surgical, Inc. buyer in Q3 2019 was Luminus Management, an estimated $2.38M added.
  • The largest Asensus Surgical, Inc. seller in Q3 2019 was JP Morgan Chase, an estimated $1.86M sold.

Based on aggregated 13F filings for Q3 2019.